Sign in

CIK 0001580149

  • Non-accelerated filer
  • Smaller reporting company

BIOVIE INC.

Sign in to watch
Ticker
BIVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
462510769
Phone
+1 775-888-3162
Business address
680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
Former names
NANOANTIBIOTICS, INC.

Securities

  • BIVI Common stock Nasdaq
  • BIVIW Warrant Nasdaq
  1. 4 Grant or award CEO & President acquired 149,500 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion CEO & President acquired 41,506 shares (option exercise)
  4. 4 Open-market sale Director sold 10,984 shares at an average $6.13 ($67,288)
  5. 4 Open-market sale Director sold 10,984 shares at an average $8.52 ($93,581)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 2,476 shares (to pay taxes)
  7. 4 Shares withheld for taxes CEO & President gave up 4,953 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 2,476 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP Neuroscience Product Dev. gave up 2,476 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP Neuroscience R&D gave up 2,476 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP Liver Cirrhosis R&D gave up 2,476 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 34,240 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 43,578 shares (grant or award)
  16. 4 Grant or award EVP Neuroscience R&D acquired 39,624 shares (grant or award)
  17. 4 Grant or award Director acquired 34,240 shares (grant or award)
  18. 4 Grant or award Chief Medical Officer acquired 39,624 shares (grant or award)
  19. 4 Grant or award EVP Neuroscience Product Dev. acquired 39,624 shares (grant or award)
  20. 4 Grant or award Director acquired 43,578 shares (grant or award)

Page 3 of 8 · 147 filings